Anti-SARS-CoV-2 Monoclonal Antibody Distribution to High-risk Medicare Beneficiaries, 2020-2021

Authors :: Caroline L. Behr
Karen E. Joynt Maddox
Ellen Meara
Arnold M. Epstein
E. John Orav
Michael L. Barnett
Source :: JAMA
Publication Year :: 2022
Abstract: This study assesses how a limited supply of monoclonal antibody therapy was allocated to patients at highest risk of severe disease among a population of fee-for-service Medicare beneficiaries with a new COVID-19 diagnosis or confirmed exposure between November 2020 and August 2021.

Subjects :: Prescription Drugs
Research Letter
Antibodies, Monoclonal
Humans
General Medicine
Medicare
Risk Assessment
United States
COVID-19 Drug Treatment

Tools